Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
Fruits
A lesson in manufacturing for you...
Set up costs for a production run would be the same if you make
10 or 1M So the bigger the run the lower the unit cost. SNG
will never be commercial, so any costs RM has disclosed are
largely irrelevant, if this ever gets to market the Pharma in question
will have their own mark up protocol.
I expect the previous costings per dose were based on treating a pandemic,
without the knowledge that our drug may only be effective is a small % of patients.
That will have an impact on costs per dose now as the potential market
is much reduced and we will be looking at a niche marketplace, and not
be manufacturing anything like the quantities imagined.
This is still seriously undervalued... Should be 10P
I think many did not fully understand the discovery RNS,
but Lorna has just given them the facts more clearly..
Buyers piling in now..... 2024 will be transformational...Lorna!
Doc.Dan
"I prefered her other persona to be honest"
Which was??? I have always posted things as I see them, when RM said he thought we
would be doing patients Winter 22/23 I believed him... Data from Sprinter Deep Dive
was very strong and I thought it would open doors for SNG... Then Jan 23 a Linkedin message from RM
that they were working hard...Nothing more... For me the penny dropped that SNG had actually
made no progress since SPRINTER results... So as an educated individual I realised that we had
been played, given false hope.... Seriously who would not change their view based on how things played out?
I genuinely think we will be told there are not enough funds to complete our P2's based on the interims.
I have been blasted for daring to suggest this, but when it happens the likes of Tommy, Gunto and Fruits
will make excuses...... Trinity will deliver a judgement from the loo seat( His Throne) and others will moan given
SNG declared they had adequate funds...... Watch this space, and if you cannot see what is obvious
then you need to take a hard look at the evidence you ignored... All IMHO!
Ghia
The conversation was clearly about our current status and you clearly understood that
when you replied.. But alas when I pointed out that there was no evidence to back
up your post, you made a pathetic attempt to deflect as you did not want to
acknowledge your falwed post.... Nothing new there ! Investing is about the future,
the past is history !
IMHO...
No longer invested here, but if FARN were protecting shareholders they would
and should suspend the share! They know the SP will fall until this matter is resolved.
Who is benefitting from the fall is the question... ? Will existing shareholders be a part
of the financing solution, or will someone get a huge slice of the pie for £1 or less..
Let's face it the Board saw this coming and the time to look at solutions was before
it became a problem, not after.... !! Dilution is the most likely outcome,
shareholders need to ensure they are not excluded... GLA...
Ghia...
Oh the irony of your post...Most likely lost on you..
"It elevates senior professional status in the industry forges strong partnerships and can foster innovation that can be brought back in-house. "
If that is the case how has it benefitted SNG after 20years..... No amount of "Status" brought
in any benefit from strong SPRINTER data, did not get us on a Platform trial, and here
we are going it alone on a P2...... You really do post rubbish!!
That's funny Tommy when you posted that you had emailed them... Or did you forget..
Fruits, you are so immature, I am not sure you are old enough to invest...
If our Board are working with any other company, even on a worthwhile project
it means that they have less time focusing on our Trials... I should not have to spell it out..
Pretty sure most got the point...
Just reread that fateful RNS... Even though we had £25 Million in cash on the day, the RNS
only mentioned Platform Trials as a way forward.... Frankly looking at it 2 years on, why
did they not decide to get back to COPD trials immediately... We had the funds to do
another P2, which could have been completed by now..... So many lost opportunities here!
I get the feeling they preserved their personal income over delivering for shareholders!
Tommy
No one has suggested this is "easy... " But 2 years on from SPRINTER
we should expect significant progress, and H1 needs to see us move forward..
You seem to be making excuses...again... I do wonder how much time our
Board spend on SNG projects... We know SH has been working with Dyson..
Have they all started to look at other income streams as if the P2's fail
then their income from SNG ends....Are they working "at Pace" I would
like to think so... We need to see some evidence!
IMHO
If the market thought this situation was serious the share would have been suspended..
It was not....This will be resolved, even though the Board should never had let this happen..
It is a setback, and shareholders deserved better, but longterm I think this will succeed...
I think we ALL hope a BP will do a JV after successful P2's..
It is our only route to a P3 ! But SNG's Board have history
giving PI's false hope at the AGM, RM famously suggesting
there was hope of dosing Patients in Winter 2022 and saying
there was a lot of interest in our SPRINTER data..It all came to nothing..
So frankly until we get P2's underway, with confirmation we have
enough funds, then assume nothing and hope for the best... IMHO!
No longer invested here, but on my watch list.
Not much consolation, but the share would have been suspended if
it were serious, so I think you are right a placement is on the cards,
and it will be resolved...BUT the Board should not have allowed this to happen !
GLA hopefully better news ahead !